Effect of hypoxia on Ad5 infection, transgene expression and replication. (Q40462233)

20 September 2017

title

Effect of hypoxia on Ad5 infection, transgene expression and replication. (English)

1 reference

20 September 2017

0 references

Shen BH

1

1 reference

20 September 2017

Hermiston TW

series ordinal

2

1 reference

20 September 2017

publication date

1 June 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

12

1 reference

20 September 2017

issue

11

1 reference

20 September 2017

page(s)

902-910

1 reference

Progress in the use of gene transfer methods to treat genetic blood diseases

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Hypoxia as a target for combined modality treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Modulation of cell death in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

HIF-1 as a target for drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Hypoxia-inducible factor-1 alpha is regulated at the post-mRNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Human Coxsackie-Adenovirus Receptor Is Colocalized With Integrins αvβ3and αvβ5on the Cardiomyocyte Sarcolemma and Upregulated in Dilated Cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Enhancement of adenovirus-mediated gene delivery by use of an oligopeptide with dual binding specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Integrin alpha(v)beta1 is an adenovirus coreceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Adenovirus type 5 uptake by lung adenocarcinoma cells in culture correlates with Ad5 fibre binding is mediated by alpha(v)beta1 integrin and can be modulated by changes in beta1 integrin function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Genetic amplification of the transcriptional response to hypoxia as a novel means of identifying regulators of angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Genome-wide analysis of the endothelial transcriptome under short-term chronic hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Target validation in hypoxia-induced vascular remodeling using transcriptome/metabolome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Oncolytic biotherapy: a novel therapeutic plafform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Modified adenoviruses for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

The emerging fields of suicide gene therapy and virotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Replicative oncolytic adenoviruses in multimodal cancer regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Virotherapeutics: conditionally replicative adenoviruses for viral oncolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Adenovirus E1A under the control of heterologous promoters: wide variation in E1A expression levels has little effect on virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Regulation of proliferation-survival decisions during tumor cell hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Control functions of adenovirus transformation region E1A gene products in rat and human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Hypoxia-mediated tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

An adenoviral vector regulated by hypoxia for the treatment of ischaemic disease and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Adenovirus-mediated transfer of BAX driven by the vascular endothelial growth factor promoter induces apoptosis in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

HIF-1 in cell cycle regulation, apoptosis, and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Adenovirus and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: impact for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

Hypoxia, HIF-1, and the pathophysiology of common human diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

7 January 2021

Hyperbaric oxygen therapy of diabetic foot ulcers, transcutaneous oxymetry in clinical decision making

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

7 January 2021

Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

7 January 2021

Trans complementation of an E1A-deleted adenovirus with codelivered E1A sequences to make recombinant adenoviral producer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302448

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302448

1 reference

Dimensions Publication ID

20 September 2017

1005301089

0 references

1 reference